Literature DB >> 26466952

Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.

Seokhwi Kim1, Minju Lee1, Hyung Jin Shin2, Joohee Lee3, Yeon-Lim Suh4.   

Abstract

INTRODUCTION: The co-occurrence of Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) is extremely rare and almost all cases were reported in adults. CASE REPORT: We describe a case of intracranial LCH and ECD that was confirmed by histopathological and molecular studies. A three-year-old boy presented with headache and right exophthalmos and brain magnetic resonance images (MRI) revealed multiple intracranial tumors. Whole body MRI showed osteolytic lesions typical of LCH in flat bones and osteosclerotic changes typical of ECD in long bones. DISCUSSION: Histologically, the biopsy samples from the posterior fossa and occipital skull mass revealed areas of both LCH and ECD. Immunohistochemically, the LCH contained CD1a-positive Langerhans cells and the ECD had CD1a-negative, CD68-positive foamy histiocytes. BRAF (V600E) mutations were detected in both the LCH and ECD areas. The coexistence of LCH and ECD in the same biopsy and the BRAF (V600E) mutation status in both histologic types support the recent re-classification of the histiocytic disorder into LCH, ECD, and "mixed histiocytosis", which reflects tumorigenesis for all three from a common progenitor cell.

Entities:  

Keywords:  BRAF mutation; Central nervous system; Erdheim-Chester disease; Langerhans cell histiocytosis; Mixed histiocytosis

Mesh:

Year:  2015        PMID: 26466952     DOI: 10.1007/s00381-015-2929-6

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

Review 1.  Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses.

Authors:  Sheila Weitzman; Ronald Jaffe
Journal:  Pediatr Blood Cancer       Date:  2005-09       Impact factor: 3.167

Review 2.  Langerhans cell histiocytosis and Erdheim-Chester disease.

Authors:  Marta Wilejto; Oussama Abla
Journal:  Curr Opin Rheumatol       Date:  2012-01       Impact factor: 5.006

Review 3.  More than just Langerhans cell histiocytosis: a radiologic review of histiocytic disorders.

Authors:  Jatin Zaveri; Quan La; Gail Yarmish; Jeremy Neuman
Journal:  Radiographics       Date:  2014 Nov-Dec       Impact factor: 5.333

4.  A common progenitor cell in LCH and ECD.

Authors:  Gayane Badalian-Very
Journal:  Blood       Date:  2014-08-14       Impact factor: 22.113

5.  Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy.

Authors:  Jun Yin; Feng Zhang; Huizhen Zhang; Li Shen; Qing Li; Shundong Hu; Qinghua Tian; Yuqian Bao; Weiping Jia
Journal:  Oncologist       Date:  2013-01-08

6.  Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study.

Authors:  Evaldas Laurencikas; Désirée Gavhed; Helen Stålemark; Ingrid van't Hooft; Daniela Prayer; Nicole Grois; Jan-Inge Henter
Journal:  Pediatr Blood Cancer       Date:  2011-02       Impact factor: 3.167

Review 7.  Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases.

Authors:  Stacy L Pineles; Grant T Liu; Xenia Acebes; Jorge Arruga; Sunita Nasta; Ruchira Glaser; Michelle Pramick; Franz Fogt; Peter Le Roux; Roberta E Gausas
Journal:  J Neuroophthalmol       Date:  2011-09       Impact factor: 3.042

Review 8.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

Review 9.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

10.  Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.

Authors:  Riccardo Haupt; Milen Minkov; Itziar Astigarraga; Eva Schäfer; Vasanta Nanduri; Rima Jubran; R Maarten Egeler; Gritta Janka; Dragan Micic; Carlos Rodriguez-Galindo; Stefaan Van Gool; Johannes Visser; Sheila Weitzman; Jean Donadieu
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

View more
  4 in total

Review 1.  Erdheim-Chester Disease: a Concise Review.

Authors:  Matthias Papo; Jean-François Emile; Thiago Trovati Maciel; Pierre Bay; Alistair Baber; Olivier Hermine; Zahir Amoura; Julien Haroche
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

2.  Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.

Authors:  Zsófia Váradi; Rita Bánusz; Judit Csomor; Krisztián Kállay; Edit Varga; Gabriella Kertész; Monika Csóka
Journal:  Onco Targets Ther       Date:  2017-01-24       Impact factor: 4.147

3.  BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.

Authors:  J Picarsic; T Pysher; H Zhou; M Fluchel; T Pettit; M Whitehead; L F Surrey; B Harding; G Goldstein; Y Fellig; M Weintraub; B C Mobley; P M Sharples; M L Sulis; E L Diamond; R Jaffe; K Shekdar; M Santi
Journal:  Acta Neuropathol Commun       Date:  2019-11-04       Impact factor: 7.801

4.  Erdheim-Chester disease: First pediatric case report in Colombia

Authors:  Luis Carlos Salazar; Luz Ángela Moreno; Lina Eugenia Jaramillo; Edgar Vladimir Cabrera
Journal:  Biomedica       Date:  2021-12-15       Impact factor: 0.935

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.